QC Kinetix: Transforming the Medical Field with Regenerative Medicine
QC Kinetix is a trailblazer in regenerative medicine, offering groundbreaking, non-surgical solutions for joint pain and other musculoskeletal discomforts. Since its founding in 2017, the company has rapidly expanded, establishing a presence in over 100 cities and serving thousands of patients through its innovative therapies.
Harnessing the body’s natural ability to heal itself, QC Kinetix uses regenerative treatments that enhance function and alleviate pain without resorting to surgery. Their patient-centered approach focuses on improving quality of life through advanced biologic therapies.
In May 2024, QC Kinetix was named one of Entrepreneur’s top 10 “2024 Top New and Emerging Franchises.” The company climbed to the No. 9 spot due to exceptional performance in unit growth, financial stability, and brand recognition. Boasting an impressive 2,111% unit growth in just three years, QC Kinetix has solidified its position as one of the top brands in the industry.
“We’re honored to rank among some of the fastest-growing franchise brands,” said the CEO of QC Kinetix. “The recognition is a testament to our team’s dedication. I’m excited to see our brand continue to push boundaries in regenerative medicine.”
A Commitment to Excellence: QC Kinetix’s Vision
QC Kinetix is dedicated to offering patients superior alternatives to pain management, avoiding invasive surgeries, addictive medications, and harmful steroid injections. This mission has driven the company’s success, enabling them to treat thousands of patients with cutting-edge biologic treatment protocols.
The recent appointment of Dr. Mitchell Sheinkop, a renowned orthopedic surgeon, as the company’s national medical director marks a significant milestone. With over 37 years of experience in joint replacement surgery, Dr. Sheinkop brings unmatched expertise to QC Kinetix.
In his role, Dr. Sheinkop leads the medical management team, enhances treatment protocols, and spearheads research initiatives. His vision includes integrating physical therapy and weight loss into existing treatments to elevate patient outcomes.
As QC Kinetix enters this new era, Dr. Sheinkop’s extensive clinical achievements and dedication to innovation position him as the ideal leader to drive the company forward.
QC Kinetix: Supported by Industry Leaders
The company’s reputation is bolstered by endorsements from prominent figures, including Pro Football Hall of Famer Emmitt Smith, QC Kinetix’s national spokesperson.
“I’ve got to keep taking care of these joints,” Smith said. “No losing for this guy. When I take QC Kinetix natural supplements, it’s like – bam – Emmitt 2.0. Sometimes, you need a competitive edge.”
The Origins of QC Kinetix
The story of QC Kinetix began with a group of visionaries—a medical doctor, physician assistant, nurse practitioner, and business professional—who wanted to revolutionize pain treatment. The name reflects their roots in Charlotte, North Carolina, known as “Queen City,” and their mission to restore motion and vitality, inspired by kinetic energy.
The founders saw an opportunity to challenge traditional pain management methods by developing a concierge medical model centered on regenerative medicine. This innovative approach focuses on restoring quality of life without reliance on insurance-driven treatment limitations.
“No longer did we want insurance to tell us what they were willing to pay to treat a patient,” explained a company spokesperson. “We wanted research to guide us to the most effective methods, regardless of insurance coverage.”
A Patient-Centered Approach
QC Kinetix empowers patients to regain their active lifestyles by offering natural biologic treatments as alternatives to surgery and medication. The company’s state-of-the-art therapies leverage the body’s healing properties to enhance function and quality of life.
Patients commonly seek treatment for joint pain in areas like the knees, hips, and shoulders. QC Kinetix treatments use the body’s natural mechanisms to promote regeneration and health. Since its nationwide expansion in 2021, the company has achieved numerous milestones, including serving over 40,000 patients by April 2024.
“It is our goal to change medicine,” the CEO of QC Kinetix stated. “We want to be the first option for pain treatment, not the alternative. Our success is measured by the lives we transform and the trust of our patients.”
Expanding Horizons: The Future of QC Kinetix
With its strong foundation in the United States, QC Kinetix is now preparing for international expansion. Plans are underway to bring its regenerative medicine services to the United Kingdom, Australia, and New Zealand in the coming years.
The company aims to operate 250 locations in the U.S. by the end of 2024, reflecting the growing demand for non-surgical pain relief options. The CEO noted, “The only thing that surprises me about our growth is that it hasn’t happened even faster, given the demand.”
As QC Kinetix continues its mission to revolutionize pain management, its commitment to innovation, patient care, and global expansion solidifies its role as a transformative leader in regenerative medicine.
“I love this brand and our future,” the CEO concluded. “It’s about impacting lives and being a game-changer in the medical field.”
